Ranier Technology adds regulatory director to staff.
Cambridge, United Kingdom-based Ranier Technology, a spinal implant developer, recently bolstered its management team with the addition of Keith Summerhayes, who will serve as director of regulatory affairs.
Summerhayes previously served as director of clinical, regulatory and quality affairs at St. Francis Medical Technologies (acquired by Kyphon). Earlier, he spent 13 years at Zimmer and Stryker. In addition, he has chaired and remains a committee member of the Institute of Clinical Research Medical Device Sub-group and is involved in key committees in the United Kingdom and European clinical trials/regulatory affairs arena.
"Keith Summerhayes joins our senior management team at an important time for Ranier as we move into the clinical testing phase for our lead CAdisc artificial spinal disc product. His highly relevant experience both in regulatory affairs and strategic aspects of high-growth orthopedic companies will be of great value to Ranier as we move towards commercializing our lead products," said Dr. Geoffrey Andrews, CEO and founder of Ranier Technology.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||PEOPLE NEWS|
|Publication:||Orthopedic Design & Technology|
|Article Type:||Brief article|
|Date:||Sep 1, 2007|
|Previous Article:||Orchid acquires 3 new orthopedic suppliers.|
|Next Article:||Former Orthofix CEO joins MAKO's board.|